Search Articles — Sudonull

https://sudonull.com/generative-ui-three-approaches-for-ai

Breakdown of three GenUI strategies: from HTML to Tambo. When to apply, pros-cons, comparison. For product managers and designers — implement adaptive interfaces without chaos.

https://sudonull.com/crispr-pencil-gene-therapy-n-1-saved-an-infant

Doctors edited a newborn's liver by assembling therapy for a unique mutation. Learn how CRISPR-pencil is changing regulation and the future of medicine.

https://sudonull.com/reqorsa-gene-therapy-analysis-of-asco-2026-data-and-prospects

Critical analysis of Reqorsa gene therapy results at ASCO-2026: sample of 18 patients, p=0.05, risks for investors and the real situation of Genprex. Read details.

https://sudonull.com/image-generation-by-references-without-text

Learn how to replace text prompts with references for precise AI art generation. Comparison of arena.ai models, post-processing pipeline. Save time on projects — read the guide for designers.

https://sudonull.com/sudoku-js-generator-bijection-and-factorials

Algorithm for generating unique Sudoku grids in JavaScript: from swaps to factorial bijection. 609 billion variants from one template. Code and math for developers.

https://ymaho.com/fda-approved-the-first-gene-therapy-for-hereditary-deafness

Regeneron's Otarmeni restores hearing to normal in 42% of patients. The therapy treats OTOF gene mutations with a single injection. Learn how AAV vector technology has for the first time restored the ability to hear a whisper.

https://ymaho.com/gene-therapy-against-aging-russian-rna-drugs-block-rage

Scientists from Russia are creating the world's first gene therapeutic drug for aging: a RAGE gene blocker and exosomes against sarcopenia. Learn how the state project promises to restore muscles and prolong active life.

https://ymaho.com/gene-therapy-of-aging-in-the-russian-federation-rage-blockade-and-sarcopenia-exosomes

Russian scientists are creating the world's first anti-aging drugs: RAGE gene blocker and exosome rejuvenation. The Ministry of Education and Science promises clinical use by 2030. Learn how transplantation of 'young' vesicles restores muscles and why the budget exceeds 2 trillion rubles.

https://ymaho.com/in-vivo-gene-editing-crispr-therapy-for-hereditary-angioedema

Single-dose CRISPR therapy NTLA-2002 reduced hereditary angioedema attacks by 87% in phase III. Learn how this will change treatment and pave the way to a cure.

https://ymaho.com/in-vivo-gene-editing-phase-3-of-hae-therapy-successful

First ever successful phase 3 in vivo gene editing: lonvo-z therapy reduces HAE attacks by 87%. Learn about the breakthrough and discontinuation of prophylaxis.

https://ymaho.com/fda-approved-first-gene-therapy-for-lad-i-in-children

FDA approved Kresladi (marnetegragene autotemcel) — the first stem cell gene therapy for children with severe LAD-I. Learn about the mechanism, precedents, and business model. Detailed analysis on the website.

https://ymaho.com/gene-therapy-opgx-lca5-accepted-into-fda-rdep-program

Learn how Opus Genetics' gene therapy OPGx-LCA5 received RDEP status from the FDA, accelerating the development of treatment for ultra-rare LCA5 blindness in children. Detailed analysis and prospects.

https://ymaho.com/gene-therapy-for-otof-deafness-hearing-restoration

FDA approved the first gene therapy for hereditary deafness Otarmeni. Learn how a single injection restores hearing in OTOF mutation and changes the market.

https://ymaho.com/gene-therapy-without-registration-russia-legalizes-bespoke-drugs

Russia will allow individual gene therapy for orphan diseases without state registration. A chance for children with deadly mutations. Learn how it works.

https://ymaho.com/gene-therapy-against-aging-hunting-the-rage-gene

Russian scientists are creating the first gene therapy that blocks the aging receptor RAGE. Learn how turning off the gene can prolong cell youth. Project details.